Magazine Article | November 1, 2021

Why Korea Is Now More Attractive To U.S. Biopharma

Source: Life Science Leader

By Sungho Han, Ph.D.

By most measures, South Korea is an attractive market for pharma companies. The population, around 51 million, is roughly equal to California and North Carolina combined. Healthcare spending per capita is rising. Seniors — who account for higher pharmaceutical spending than other demographics — make up more than 16% of the population. Ranked by total spending, South Korea is among the top 15 markets for pharmaceutical sales.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: